BRPI0602614A - use of deamified starch in extrusion - spheronization of pharmaceutical pellets - Google Patents

use of deamified starch in extrusion - spheronization of pharmaceutical pellets

Info

Publication number
BRPI0602614A
BRPI0602614A BRPI0602614A BRPI0602614A BR PI0602614 A BRPI0602614 A BR PI0602614A BR PI0602614 A BRPI0602614 A BR PI0602614A BR PI0602614 A BRPI0602614 A BR PI0602614A
Authority
BR
Brazil
Prior art keywords
spheronization
extrusion
starch
deamified
pharmaceutical pellets
Prior art date
Application number
Other languages
Portuguese (pt)
Inventor
Aleksandra Dukic
Chris Vervaet
Jean Paul Remon
Paul A Altieri
Paul B Foreman
Original Assignee
Nat Starch Chem Invest
Univ Gent
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nat Starch Chem Invest, Univ Gent filed Critical Nat Starch Chem Invest
Publication of BRPI0602614A publication Critical patent/BRPI0602614A/en

Links

Landscapes

  • Medicinal Preparation (AREA)

Abstract

"UTILIZAçãO DE AMIDO DESRAMIFICADO NA EXTRUSãO-ESFERONIZAçãO DE PELOTAS FARMACêUTICAS". Esta patente relaciona-se à utilização de amido desramificado na preparação de pelotas farmacêuticas por extrusão-esferonização. Tais excipientes são úteis em qualquer forma de dosagem seca, incluindo tabletes e cápsulas, tanto para liberação imediata quanto para liberação sustentada."USE OF DAMAGED STARCH IN EXTRUSION-SPHERONIZATION OF PHARMACEUTICAL PELLETS". This patent relates to the use of deamified starch in the preparation of pharmaceutical pellets by extrusion-spheronization. Such excipients are useful in any dry dosage form, including tablets and capsules, for both immediate release and sustained release.

BRPI0602614 2005-05-02 2006-04-28 use of deamified starch in extrusion - spheronization of pharmaceutical pellets BRPI0602614A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US67718205P 2005-05-02 2005-05-02

Publications (1)

Publication Number Publication Date
BRPI0602614A true BRPI0602614A (en) 2006-12-26

Family

ID=37546512

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0602614 BRPI0602614A (en) 2005-05-02 2006-04-28 use of deamified starch in extrusion - spheronization of pharmaceutical pellets

Country Status (3)

Country Link
CN (1) CN101024084B (en)
BR (1) BRPI0602614A (en)
ZA (1) ZA200603392B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20110073618A (en) * 2008-10-23 2011-06-29 헨켈 코포레이션 Vaginal pellets comprising debranched starch

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5049394A (en) * 1987-09-11 1991-09-17 E. R. Squibb & Sons, Inc. Pharmaceutical composition containing high drug load and method for preparing same
US5468286A (en) * 1989-10-25 1995-11-21 National Starch And Chemical Investment Holding Corporation Enzymatically debranched starches as tablet excipients
US7081261B2 (en) * 2002-05-14 2006-07-25 National Starch And Chemical Investment Holding Corporation Resistant starch prepared by isoamylase debranching of low amylose starch

Also Published As

Publication number Publication date
CN101024084B (en) 2012-07-04
ZA200603392B (en) 2007-01-31
CN101024084A (en) 2007-08-29

Similar Documents

Publication Publication Date Title
CL2018003398A1 (en) Pharmaceutical sustained release composition comprising micro-particles. (application division 2013-03538).
MY139086A (en) Use of debranched starch in extrusion-spheronization pharmaceutical pellets
CO6321225A2 (en) SOLID CARRIER PARTICLES TO IMPROVE THE PROCESSABILITY OF A PHARMACEUTICAL AGENT
IL183357A0 (en) Oral medicament for the modified release of at least one active principle, in multimicrocapsule form
IL184758A0 (en) New pharmaceutical compositions useful in the transmucosal administration of drugs
IL187475A (en) Oral solid dosage form comprising a first population of microparticles for the modified release of at least one analgesic active principle and a second population of microparticles containing at least one quenching agent and uses thereof
CU20080052A7 (en) SOLID PHARMACEUTICAL PRESENTATION FORMS OF ORAL ADMINISTRATION WITH QUICK RELEASE OF ACTIVE PRINCIPLE
UY29856A1 (en) CRYSTAL FORM 8D OF IVABRADINE CHLORHYDRATE, ITS PREPARATION PROCEDURE, AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING IT
WO2007038459A3 (en) Carboxyamine compounds and their use in the treatment of hdac dependent diseases
DK1545467T3 (en) Solid pharmaceutical formulations comprising telmisartan
IL195269A0 (en) Pharmaceutical formulations for the sustained release of active ingredient(s), as well as their applications, especially therapeutic
ATE505203T1 (en) PHARMACEUTICAL COMBINATION OF ALISKIREN AND VALSARTAN
IS7564A (en) Medicinal product with modified release
NO20082047L (en) Slow release composition, process for its preparation and use thereof
CL2010001362A1 (en) Pharmaceutical dosage form for immediate release of the active substance 3-z- [1- (4- (n - ((4-methyl-piperazin-1-yl) -methylcarbonyl) -n-methyl-amino) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone-monoethanesulfonate; and its use for the treatment and / or prevention of oncological and immunological diseases, among others.
BRPI0717369A2 (en) COMPOUND, MEDICINAL PRODUCT, PHARMACEUTICAL COMPOSITION CONTAINING AND USE OF THE COMPOUND.
ITFI20050041A1 (en) HYDROXAMMED AS INHIBITORS OF ISTONE DEACELITASIS, THEIR PREPARATION AND PHARMACEUTICAL FORMULATIONS THAT CONTAIN THEM
CO6270217A2 (en) GALENIC FORMULATIONS OF ALISQUIRENO AND VALSARTAN
CL2008003799A1 (en) Pharmaceutical composition comprising raloxifene in immediate release tablet form; Useful for the treatment and / or prevention of osteoporosis.
ATE327759T1 (en) SUSTAINED RELEASE PHARMACEUTICAL COMPOSITION
NO20070187L (en) Orally disintegrating pharmaceutical composition comprising risperidone
BRPI0614413A2 (en) compound and pharmaceutical composition
ATE448780T1 (en) MODIFIED RELEASE PHARMACEUTICAL MODAFINIL COMPOSITIONS
BRPI0614412A2 (en) compound and pharmaceutical composition
BRPI0602614A (en) use of deamified starch in extrusion - spheronization of pharmaceutical pellets

Legal Events

Date Code Title Description
B08F Application fees: dismissal - article 86 of industrial property law

Free format text: REFERENTE AS 5A E 6A ANUIDADES.

B08K Maintenance of archiving: application remains archived as no request for restauration (art. 87) has been received.

Free format text: NAO APRESENTADA A GUIA DE CUMPRIMENTO DE EXIGENCIA. REFERENTE AS 5A E 6A ANUIDADES.